Gelonghui, April 15 | Kaisai Biotech (688065.SH), which reached a record low last Friday, experienced a rebound. It has now risen 6.5% to 39.95 yuan, with a market value of 23.3 billion yuan. According to the news, the company's net profit for the first quarter was 94 million yuan to 115 million yuan, an increase of 63.65% to 100.20% over the previous year. During the period, sales volume and sales revenue of long-chain binary acids rose sharply compared to the same period last year. According to Shen Wan Hongyuan's research review, the company's demand for long-chain binary acids is picking up, and he is looking forward to commercializing the application of bio-based composites and maintaining the “gain” rating.
A股异动丨发盈喜，凯赛生物反弹6.5%
A-share changes丨Fa Yingxi, Kaisai Biotech rebounds 6.5%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.